Douglas Janzen

Douglas Janzen

Chief Executive Officer chez AEQUUS PHARMACEUTICALS INC.

Fortune : 138 092 $ au 31/03/2024

56 ans
Health Technology
Commercial Services
Finance

Profil

Douglas Glen Janzen is the founder and currently holds the position of Chairman, President & Chief Executive Officer at Aequus Pharmaceuticals, Inc., which was founded in 2013.
He is also the founder and currently serves as President, Chief Executive Officer & MD at Northview Ventures, Inc., founded in 2012.
Additionally, he is the founder and currently holds the position of Managing Director at Northview Ventures & Associates General Partnership, founded in 2014.
Mr. Janzen's current job(s) include being the Chairman at Lexington Biosciences Holdings Corp., starting in 2017.
He is also the Director & Managing Director at LifeSciences British Columbia since 2010, an Independent Director at Neovasc, Inc. since 2005, and a Director at Perimeter Medical Imaging, Inc., Synaptive Technologies Ltd., Transdermal Research Pharm Laboratories LLC, and Alabaster Technologies, Inc. In his former positions, Mr. Janzen served as the President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2003 to 2012.
He was also the Chairman at AbCellera Biologics, Inc. and Lexington Biosciences, Inc. from 2016 to 2021.
Furthermore, he held various director positions at Medical Ventures Corp., Teal Valley Health, Inc., Aptamera, Inc., Synaptive Medical, Inc., BIOTECanada, iCo Therapeutics, Inc., Sentinelle Medical ULC, BioHEP Technologies Ltd., Renaissance BioScience Corp., AmpHP, Inc., and Perimeter Medical Imaging AI, Inc. He also worked as an Analyst at Cormark Securities, Inc. in 2002 and served as the President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007.
Prior to that, he was the Head of Research at Loewen, Ondaatje, McCutcheon Ltd.
from 1998 to 2001.
Mr. Janzen's education includes a graduate degree from the University of British Columbia and an undergraduate degree from the University of Saskatchewan.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/06/2023 12 553 800 ( 9,46% ) 138 092 $ 31/03/2024

Postes actifs de Douglas Janzen

SociétésPosteDébut
NEOVASC INC. Director/Board Member 02/06/2005
AEQUUS PHARMACEUTICALS INC. Chief Executive Officer 03/01/2013
Alabaster Technologies, Inc. Director/Board Member -
Chairman 23/05/2017
Chief Executive Officer 01/04/2014
Transdermal Research Pharm Laboratories LLC Director/Board Member 03/03/2013
Synaptive Technologies Ltd. Director/Board Member -
Northview Ventures, Inc. Chief Executive Officer 01/11/2012
Director/Board Member -
Tous les postes actifs de Douglas Janzen

Anciens postes connus de Douglas Janzen

SociétésPosteFin
░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Douglas Janzen

Formation de Douglas Janzen

University of British Columbia Graduate Degree
University of Saskatchewan Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Janzen

Relations

100 +

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
AEQUUS PHARMACEUTICALS INC.

Health Technology

ABCELLERA BIOLOGICS INC.

Health Technology

REGISTERED PLAN PRIVATE INVESTMENTS INC.

Health Technology

PERIMETER MEDICAL IMAGING AI, INC.

Health Technology

Entreprise privées23

Finance

Health Technology

Electronic Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Northview Ventures, Inc.

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Health Technology

Alabaster Technologies, Inc.

Health Technology

Transdermal Research Pharm Laboratories LLC

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Janzen